vs

Side-by-side financial comparison of Lake Shore Bancorp, Inc. (LSBK) and Vivos Therapeutics, Inc. (VVOS). Click either name above to swap in a different company.

Lake Shore Bancorp, Inc. is the larger business by last-quarter revenue ($7.4M vs $3.8M, roughly 1.9× Vivos Therapeutics, Inc.). Lake Shore Bancorp, Inc. runs the higher net margin — 31.8% vs -180.3%, a 212.0% gap on every dollar of revenue. Lake Shore Bancorp, Inc. produced more free cash flow last quarter ($3.3M vs $-5.3M).

Lake Shore Bancorp, Inc. (Maryland) is a U.S. regional bank holding company that operates via its banking subsidiary, offering retail and commercial banking services including deposits, loans, mortgages and wealth management, primarily serving individuals and SMEs across local communities in Maryland.

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

LSBK vs VVOS — Head-to-Head

Bigger by revenue
LSBK
LSBK
1.9× larger
LSBK
$7.4M
$3.8M
VVOS
Higher net margin
LSBK
LSBK
212.0% more per $
LSBK
31.8%
-180.3%
VVOS
More free cash flow
LSBK
LSBK
$8.6M more FCF
LSBK
$3.3M
$-5.3M
VVOS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
LSBK
LSBK
VVOS
VVOS
Revenue
$7.4M
$3.8M
Net Profit
$2.4M
$-6.9M
Gross Margin
78.1%
Operating Margin
38.4%
-166.8%
Net Margin
31.8%
-180.3%
Revenue YoY
3.4%
Net Profit YoY
-143.8%
EPS (diluted)
$0.32
$-0.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LSBK
LSBK
VVOS
VVOS
Q4 25
$3.8M
Q3 25
$7.4M
$6.8M
Q2 25
$6.9M
$3.8M
Q1 25
$3.0M
Q4 24
$3.7M
Q3 24
$3.9M
Q2 24
$4.1M
Q1 24
$3.4M
Net Profit
LSBK
LSBK
VVOS
VVOS
Q4 25
$-6.9M
Q3 25
$2.4M
$-5.4M
Q2 25
$1.9M
$-5.0M
Q1 25
$-3.9M
Q4 24
$-2.8M
Q3 24
$-2.6M
Q2 24
$-1.9M
Q1 24
$-3.8M
Gross Margin
LSBK
LSBK
VVOS
VVOS
Q4 25
78.1%
Q3 25
58.0%
Q2 25
55.2%
Q1 25
50.0%
Q4 24
56.7%
Q3 24
60.5%
Q2 24
65.4%
Q1 24
56.7%
Operating Margin
LSBK
LSBK
VVOS
VVOS
Q4 25
-166.8%
Q3 25
38.4%
-69.8%
Q2 25
33.2%
-127.4%
Q1 25
-129.9%
Q4 24
-75.9%
Q3 24
-68.5%
Q2 24
-47.8%
Q1 24
-110.7%
Net Margin
LSBK
LSBK
VVOS
VVOS
Q4 25
-180.3%
Q3 25
31.8%
-79.6%
Q2 25
27.7%
-131.2%
Q1 25
-128.1%
Q4 24
-76.4%
Q3 24
-67.8%
Q2 24
-47.6%
Q1 24
-110.1%
EPS (diluted)
LSBK
LSBK
VVOS
VVOS
Q4 25
$-0.58
Q3 25
$0.32
$-0.49
Q2 25
$0.34
$-0.55
Q1 25
$-0.45
Q4 24
$0.41
Q3 24
$-0.40
Q2 24
$-0.60
Q1 24
$-1.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LSBK
LSBK
VVOS
VVOS
Cash + ST InvestmentsLiquidity on hand
$83.6M
$2.0M
Total DebtLower is stronger
$2.0M
$2.9M
Stockholders' EquityBook value
$139.3M
$-1.5M
Total Assets
$742.8M
$25.2M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LSBK
LSBK
VVOS
VVOS
Q4 25
$2.0M
Q3 25
$83.6M
$3.1M
Q2 25
$75.4M
$4.4M
Q1 25
$2.3M
Q4 24
$6.3M
Q3 24
$6.3M
Q2 24
$6.9M
Q1 24
$2.6M
Total Debt
LSBK
LSBK
VVOS
VVOS
Q4 25
$2.9M
Q3 25
$2.0M
Q2 25
$2.0M
Q1 25
Q4 24
$1.2M
Q3 24
$1.2M
Q2 24
$1.2M
Q1 24
Stockholders' Equity
LSBK
LSBK
VVOS
VVOS
Q4 25
$-1.5M
Q3 25
$139.3M
$2.5M
Q2 25
$92.9M
$4.6M
Q1 25
$4.4M
Q4 24
$8.0M
Q3 24
$7.7M
Q2 24
$6.3M
Q1 24
$582.0K
Total Assets
LSBK
LSBK
VVOS
VVOS
Q4 25
$25.2M
Q3 25
$742.8M
$25.6M
Q2 25
$734.8M
$26.0M
Q1 25
$11.3M
Q4 24
$15.3M
Q3 24
$15.3M
Q2 24
$15.8M
Q1 24
$11.8M
Debt / Equity
LSBK
LSBK
VVOS
VVOS
Q4 25
Q3 25
0.01×
Q2 25
0.02×
Q1 25
Q4 24
0.15×
Q3 24
0.16×
Q2 24
0.19×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LSBK
LSBK
VVOS
VVOS
Operating Cash FlowLast quarter
$3.3M
$-3.8M
Free Cash FlowOCF − Capex
$3.3M
$-5.3M
FCF MarginFCF / Revenue
44.4%
-139.7%
Capex IntensityCapex / Revenue
0.6%
40.0%
Cash ConversionOCF / Net Profit
1.42×
TTM Free Cash FlowTrailing 4 quarters
$-17.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LSBK
LSBK
VVOS
VVOS
Q4 25
$-3.8M
Q3 25
$3.3M
$-4.2M
Q2 25
$2.5M
$-3.5M
Q1 25
$-3.8M
Q4 24
$-2.9M
Q3 24
$-4.2M
Q2 24
$-3.0M
Q1 24
$-2.5M
Free Cash Flow
LSBK
LSBK
VVOS
VVOS
Q4 25
$-5.3M
Q3 25
$3.3M
$-4.2M
Q2 25
$2.0M
$-4.3M
Q1 25
$-3.9M
Q4 24
$-3.1M
Q3 24
$-4.4M
Q2 24
$-3.1M
Q1 24
$-2.7M
FCF Margin
LSBK
LSBK
VVOS
VVOS
Q4 25
-139.7%
Q3 25
44.4%
-62.6%
Q2 25
28.5%
-111.6%
Q1 25
-129.9%
Q4 24
-84.0%
Q3 24
-113.4%
Q2 24
-76.7%
Q1 24
-78.0%
Capex Intensity
LSBK
LSBK
VVOS
VVOS
Q4 25
40.0%
Q3 25
0.6%
1.2%
Q2 25
7.7%
20.2%
Q1 25
4.0%
Q4 24
4.5%
Q3 24
5.0%
Q2 24
1.5%
Q1 24
4.4%
Cash Conversion
LSBK
LSBK
VVOS
VVOS
Q4 25
Q3 25
1.42×
Q2 25
1.31×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LSBK
LSBK

Segment breakdown not available.

VVOS
VVOS

Services$3.2M84%
Products$594.0K16%

Related Comparisons